(Press-News.org) The EULAR 2025 Congress will gather the world's foremost rheumatology experts, fostering a unique environment to explore pioneering research, clinical advancements, and patient-centred innovations in rheumatology. This annual flagship event offers unparalleled access to transformative discussions and showcases the latest strides in patient care for rheumatic and musculoskeletal diseases (RMDs).
This year's Congress programme promises an impressive line-up, featuring must-see scientific sessions, EULAR Recommendations, and insightful abstract presentations. Esteemed speakers from across Europe and beyond will lead symposia, delve into new treatment approaches, and discuss the evolving landscape of research and management of RMDs.
Exclusive Interview Opportunities with Key Speakers
Building on the success of the EULAR 2024 Official Press Conference, we are excited to welcome media representatives once again to the EULAR 2025 Official Press Conference onsite in Barcelona on 12 June. The event will be followed by a press lunch and a unique opportunity to conduct one-on-one interviews with our distinguished panel speakers. This is a valuable chance for journalists to directly engage with leading experts on topics crucial to their audiences.
We warmly invite journalists and media outlets specialising in healthcare, science, research and patient advocacy to apply for press accreditation. Accredited press representatives will have access to Congress activities, including the opening plenary, scientific sessions, abstract presentations, the official press conference, and exclusive interview opportunities.
How to Register
To secure your press accreditation, please visit the EULAR 2025 - Press Registration page and complete your registration. We encourage early registration, as spaces for one-on-one interviews are limited. Confirmed participants will receive interview sign-up details as part of their accreditation package. For additional information on press registration requirements, visit EULAR 2025 - Press Registration page.
We look forward to welcoming you to Barcelona for an inspiring and impactful EULAR 2025 Congress.
About EULAR
EULAR is the European umbrella organisation representing scientific societies, health professional associations and organisations for people with rheumatic and musculoskeletal diseases (RMDs). EULAR aims to reduce the impact of RMDs on individuals and society, as well as improve RMD treatments, prevention, and rehabilitation. To this end, EULAR fosters excellence in rheumatology education and research, promotes the translation of research advances into daily care, and advocates for the recognition of the needs of those living with RMDs by EU institutions.
Contact
EULAR Press Office, press@eular.org
Notes to Editors
EULAR Press Releases
EULAR 2025 - Congress
EULAR Recommendations
EULAR School of Rheumatology
END
Press registration now open for the EULAR 2025 Congress in Barcelona
2024-11-01
ELSE PRESS RELEASES FROM THIS DATE:
New research identifies ways to protect neurons from the negative effect of high-fat diet on multiple sclerosis progression
2024-11-01
NEW YORK, November 1, 2024 — Newly published research in the journal Glia has identified crucial links between dietary choices and the progression of multiple sclerosis (MS). The study, led by Patrizia Casaccia, founding director of the Advanced Science Research Center at the CUNY Graduate Center’s (CUNY ASRC) Neuroscience Initiative and Einstein Professor of Biology and Biochemistry at the CUNY Graduate Center, explored how enzymes called ceramide synthase 5 and 6 are responsible for the toxic effect ...
Boosting the nutritional value of black soldier fly larvae with biotechnology
2024-11-01
With the rapid increase in the global population, a "protein crisis" is expected in the near future, where the supply of protein will not be able to meet the rising demand. Fishmeal is the most common protein source that supports the production of livestock and aquaculture products, which are key protein sources for human consumption. However, global shortage of fishmeal and its rising prices have created an urgent need to find and secure an alternative protein source. Insects are gaining attention as novel protein sources ...
Medication decisions in pregnancy: A balancing act
2024-11-01
Most women use medication during pregnancy. Yet, selecting appropriate drugs and doses is challenging. In a new The Lancet article, physicians and researchers from the Radboud university medical center, Maastricht UMC+, Imperial College London, and the University of Liverpool introduce a shared decision-making approach combining ethical principles and a pregnant woman’s values with existing evidence. They use the example of sertraline, a commonly prescribed antidepressant in pregnancy, to illustrate the advocated decision-making process.
Although pregnant women often need medication, data on drug safety and efficacy in pregnancy remains limited. Historically seen as vulnerable research ...
Texas Tech researcher named Station Science Leader for Antarctica project
2024-10-31
Summary:
Texas Tech’s Natasja van Gestel has been named Station Science Leader by the National Science Foundation (NSF), enabling her to lead and coordinate research at Antarctica’s Palmer Station while advancing her work on climate change’s impact on glaciers. As a leader, she will oversee multiple scientific initiatives, manage resources and ensure compliance with the Antarctic Treaty’s regulations.
Why This Matters:
Climate Study: Her research contributes vital data on climate change effects in Antarctica, crucial for global climate assessments.
International Collaboration: ...
Restricting sugar consumption in utero and in early childhood significantly reduces risk of midlife chronic disease
2024-10-31
A low-sugar diet in utero and in the first two years of life can meaningfully reduce the risk of chronic diseases in adulthood, a new study has found, providing compelling new evidence of the lifelong health effects of early-life sugar consumption.
Published in Science, the study finds that children who experienced sugar restrictions during their first 1,000 days after conception had up to 35% lower risk of developing Type 2 diabetes and as much as 20% less risk of hypertension as adults. Low sugar intake by the mother prior to birth was enough to lower risks, but ...
Apixaban vs aspirin in patients with cancer and cryptogenic stroke
2024-10-31
New Orleans - Ochsner Health physicians Dr. Richard Zweifler and Dr. Joseph Tarsia are co-authors on a post hoc analysis carried out in the ARCADIA randomized clinical trial, comparing the effectiveness of apixaban versus aspirin in preventing adverse clinical outcomes in patients with a history of cancer and cryptogenic stroke. The research found no significant difference in the risk of major ischemic and hemorrhagic events between those taking apixaban and aspirin. The ...
Can magnetic pulses aimed at the brain treat insomnia?
2024-10-31
Traditional solutions for sleep disorders, including medications and cognitive behavioral therapies, often provide insufficient relief for military personnel, a problem researchers from the University of Arizona College of Medicine – Tucson will be hoping to solve with a $3 million grant from the Department of Defense Congressionally Directed Medical Research Program.
Sleep problems are among the top health concerns of military personnel, with an estimated 85% meeting criteria for a clinically relevant sleep ...
F.M. Kirby Research Center honors 25 years of pioneering brain imaging research
2024-10-31
BALTIMORE, October 31, 2024— Kennedy Krieger Institute is proud to celebrate the 25th anniversary of the F.M. Kirby Research Center for Functional Brain Imaging at Kennedy Krieger Institute, a leader in advancements and research in understanding the human brain.
Established in 1999 in partnership with Johns Hopkins University School of Medicine, the center has transformed neuroscience and medical imaging by developing cutting-edge magnetic resonance imaging (MRI) techniques that allow researchers to examine and measure brain function and structure ...
$1.75M CDC grant funds study to boost vaccine acceptance in Arizona’s rural, border communities
2024-10-31
Researchers at the University of Arizona’s Mel and Enid Zuckerman College of Public Health received a $1.75 million Centers for Disease Control and Prevention grant to conduct a community-based, participatory research study designed to improve vaccine uptake in Arizona’s rural and border communities.
Vaccination is a highly effective public health intervention that saves millions of lives per year, yet vaccination rates have declined in recent years for a variety of reasons, ranging from safety concerns to religious and philosophical objections.
“Vaccination is a cornerstone of public health,” said co-principal investigator Tomas ...
Immune system review provides insight into more effective biotechnology
2024-10-31
Macrophage cells are the immune system’s frontline soldiers, early on the scene to protect the body from foreign invaders. These cells answer the immune system's critical question for the rest of its troops: friend or foe?
As critical responders, macrophages can perceive helpful biotechnology as threats. If not created with the right materials or mechanical forces, these devices can trigger an immune response that can cause inflammation, scar tissue or device failure.
But what is the right material or the right mechanical force? In a meta-analysis co-led ...